ProfileGDS4718 / 63009_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 79% 77% 83% 82% 88% 89% 84% 80% 83% 84% 80% 88% 89% 86% 83% 83% 88% 88% 77% 84% 84% 81% 83% 84% 89% 83% 86% 83% 88% 83% 85% 77% 83% 86% 86% 92% 84% 84% 79% 83% 91% 83% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.5056785
GSM549102patient 115, normal, homogenized [OPG study]7.653779
GSM549104patient 119, normal, homogenized [OPG study]7.6243577
GSM549108patient 138, normal, homogenized [OPG study]8.1504383
GSM549119patient 077, normal, homogenized [OPG study]8.0152982
GSM549133patient 032, cancer, homogenized [OPG study]8.9999988
GSM549139patient 042, cancer, homogenized [OPG study]9.0085389
GSM549099patient 107, normal, homogenized [OPG study]8.3274784
GSM549109patient 139, normal, homogenized [OPG study]7.824380
GSM549110patient 046, normal, homogenized [OPG study]8.19783
GSM549114patient 063, normal, homogenized [OPG study]8.4624884
GSM549122patient 082, normal, homogenized [OPG study]7.8644380
GSM549134patient 033, cancer, homogenized [OPG study]8.9717388
GSM549136patient 036, cancer, homogenized [OPG study]9.1374889
GSM549140patient 044, cancer, homogenized [OPG study]8.6751286
GSM549111patient 047, normal, homogenized [OPG study]8.3105383
GSM549113patient 057, normal, homogenized [OPG study]8.3040483
GSM549132patient 031, cancer, homogenized [OPG study]8.8150888
GSM549137patient 038, cancer, homogenized [OPG study]8.878488
GSM549142patient 047, cancer, homogenized [OPG study]7.3492977
GSM549100patient 110, normal, homogenized [OPG study]8.2553584
GSM549107patient 135, normal, homogenized [OPG study]8.3121284
GSM549115patient 068, normal, homogenized [OPG study]8.1084381
GSM549116patient 072, normal, homogenized [OPG study]8.2544383
GSM549120patient 078, normal, homogenized [OPG study]8.2886584
GSM549131patient 030, cancer, homogenized [OPG study]9.1132789
GSM549118patient 074, normal, homogenized [OPG study]8.2347783
GSM549129patient 027, cancer, homogenized [OPG study]8.4969786
GSM549123patient 088, normal, homogenized [OPG study]8.2341183
GSM549124patient 006, cancer, homogenized [OPG study]8.7569888
GSM549126patient 015, cancer, homogenized [OPG study]8.2212583
GSM549128patient 025, cancer, homogenized [OPG study]8.4945385
GSM549103patient 117, normal, homogenized [OPG study]7.4040577
GSM549117patient 073, normal, homogenized [OPG study]8.2546783
GSM549138patient 041, cancer, homogenized [OPG study]8.6793786
GSM549141patient 045, cancer, homogenized [OPG study]8.7513486
GSM549130patient 028, cancer, homogenized [OPG study]9.3985792
GSM549101patient 111, normal, homogenized [OPG study]8.3539284
GSM549105patient 128, normal, homogenized [OPG study]8.2432784
GSM549106patient 134, normal, homogenized [OPG study]7.9132879
GSM549112patient 048, normal, homogenized [OPG study]8.2183
GSM549125patient 011, cancer, homogenized [OPG study]9.2415391
GSM549127patient 024, cancer, homogenized [OPG study]8.1774483
GSM549135patient 035, cancer, homogenized [OPG study]9.2561190